Access cutting-edge drug-resistant epilepsy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access drug-resistant epilepsy specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related drug-resistant epilepsy treatment provided free
This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).
Sponsor: NaviFUS Corporation
Check if you qualify for this drug-resistant epilepsy clinical trial in Palo Alto, CA
If you're searching for drug-resistant epilepsy treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced drug-resistant epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.